Through its tie-up with Concord Healthcare, AIA aims to help insured employees access advanced cancer treatment across the border in Guangzhou at lower cost.
The captive's capital position strengthened in 2024 through profit retention and favourable investment gains, offsetting pressures from underwriting inefficiencies.
The rating agency also revised the outlook to stable, from positive, with the Chinese health insurer demonstrating a very strong balance sheet and steady investment income.
